Anchin L. Scott's Insider Trades & SAST Disclosures
Anchin L. Scott's most recent trade in Genasys Inc was a trade of 30,000 Common Stock done . Disclosure was reported to the exchange on March 14, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Anchin L. Scott.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Genasys Inc | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 30,000 | 298,152 (0%) | 0% | - | Common Stock | |
| Genasys Inc | L. Scott Anchin | Director | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 13 Dec 2023 | 20,000 | 268,152 (0%) | 0% | 1.9 | 37,000 | Common stock |
| Genasys Inc | Anchin L. Scott | Director | Purchase of securities on an exchange or from another person at price $ 1.73 per share. | 13 Dec 2023 | 8,000 | 248,152 (0%) | 0% | 1.7 | 13,840 | Common stock |
| Kopin Corp. | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 10,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Kopin Corp. | Scott L. Anchin | Director | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 16 May 2023 | 2,500 | 2,500 (0%) | 0% | 1.2 | 3,075 | Common Stock |
| Kopin Corp. | Scott L. Anchin | Director | Purchase of securities on an exchange or from another person at price $ 1.22 per share. | 16 May 2023 | 2,500 | 2,500 (0%) | 0% | 1.2 | 3,050 | Common Stock |
| Genasys Inc | Scott L. Anchin | Director | Purchase of securities on an exchange or from another person at price $ 2.42 per share. | 12 May 2023 | 2,500 | 2,500 (0%) | 0% | 2.4 | 6,050 | Common stock |
| Genasys Inc | Scott L. Anchin | Director | Purchase of securities on an exchange or from another person at price $ 2.38 per share. | 12 May 2023 | 2,500 | 2,500 (0%) | 0% | 2.4 | 5,950 | Common stock |
| Genasys Inc | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 30,000 | 240,152 (0%) | 0% | - | Common Stock | |
| Genasys Inc | Scott L. Anchin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.62 per share. | 08 Mar 2023 | 30,000 | 224,238 (0%) | 0% | 1.6 | 48,600 | Common stock |
| Genasys Inc | Scott L. Anchin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.45 per share. | 08 Mar 2023 | 14,086 | 210,152 (0%) | 0% | 3.5 | 48,597 | Common stock |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 75,099 | 75,099 | - | - | Incentive Stock Option (right to buy) | |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 37,550 | 37,550 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kopin Corp. | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 10,000 | 40,000 (0%) | 0% | 0 | Common Stock | |
| Genasys Inc | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 30,000 | 194,238 (0%) | 0% | - | Common Stock | |
| Genasys Inc | Scott L. Anchin | Director | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 29 Nov 2021 | 5,500 | 162,405 (0%) | 0% | 4.2 | 23,100 | Common Stock |
| Genasys Inc | Scott L. Anchin | Director | Purchase of securities on an exchange or from another person at price $ 5.35 per share. | 14 Sep 2021 | 5,000 | 156,905 (0%) | 0% | 5.4 | 26,750 | Common Stock |
| Kopin Corp. | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 10,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Genasys Inc | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 27,883 | 153,738 (0%) | 0% | - | Common Stock | |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Sale of securities on an exchange or to another person at price $ 8.43 per share. | 10 Mar 2021 | 11,999 | 1,300 (0%) | 0% | 8.4 | 101,152 | Common Stock |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Sale of securities on an exchange or to another person at price $ 8.45 per share. | 10 Mar 2021 | 610 | 480 (0%) | 0% | 8.5 | 5,155 | Common Stock |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Sale of securities on an exchange or to another person at price $ 8.47 per share. | 10 Mar 2021 | 210 | 1,090 (0%) | 0% | 8.5 | 1,779 | Common Stock |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Sale of securities on an exchange or to another person at price $ 8.51 per share. | 10 Mar 2021 | 201 | 279 (0%) | 0% | 8.5 | 1,711 | Common Stock |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Sale of securities on an exchange or to another person at price $ 8.52 per share. | 10 Mar 2021 | 29 | 250 (0%) | 0% | 8.5 | 247 | Common Stock |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 20,834 | 0 | - | - | Stock Option (right to buy) | |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.26 per share. | 05 Mar 2021 | 9,217 | 9,467 (0%) | 0% | 4.3 | 39,264 | Common Stock |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 9,121 | 0 | - | - | Stock Option (right to buy) | |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.43 per share. | 05 Mar 2021 | 3,832 | 13,299 (0%) | 0% | 4.4 | 16,976 | Common Stock |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2020 | 18,465 | 18,465 | - | - | Stock Option (right to buy) | |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2020 | 5,573 | 5,573 | - | - | Stock Option (right to buy) | |
| Genasys Inc | Scott L. Anchin | Director | Purchase of securities on an exchange or from another person at price $ 4.67 per share. | 18 Aug 2020 | 5,900 | 121,905 (0%) | 0% | 4.7 | 27,553 | Common stock |
| Genasys Inc | Scott L. Anchin | Director | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 18 Aug 2020 | 3,950 | 3,950 (0%) | 0% | 4.6 | 18,170 | Common stock |
| Kopin Corp. | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 10,000 | 20,000 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges